ADENOCARCINOMA OF THE CERVIX - ARE THERE ARGUMENTS FOR A DIFFERENT TREATMENT POLICY

Adenocarcinoma of the cervix may well be aetiologically, epidemiologic ally, and clinically different to its squamous counterpart, Overall pr ognosis is poorer which may relate to an increased radiation resistanc e or to a propensity to spread intraperitoneally. The role of neoadjuv ant and adjuvant therapy is even less well defined than in squamous ca ncers, Future studies in carcinoma of the cervix should either be conf ined to one histological type, or should at least be stratified, based on whether the disease is squamous or non-squamous.